McDonnell Boehnen Hulbert & Berghoff LLP was an exhibitor at the 2016 BIO International Convention in San Francisco June 6-9. During the event, we networked with colleagues from around the world at our booth, attended convention sessions and hosted our annual reception at Kells Irish Pub, where more than 300 attendees joined us for an evening of food, drinks and fun.  

 

Thank you to everyone who helped to make BIO 2016 a success. We look forward to seeing you next year at BIO 2017 in San Diego!

Patent Docs Talk BIO

To find out what the Patent Docs had to say about the hottest topics from BIO and what’s coming next for the industry, check out the links below:

BIO International Convention 2016 Preview: U.S. Patent Practice – the PTAB, Federal Courts, and Patent Eligibility, June 6

 

BIO International Convention 2016 Preview, June 1

 

2016 BIO International Convention, May 28

MBHB Partners Talk BIO with Media

Throughout the week, MBHB partners shared biotech and IP insights with reporters from outlets including Forbes and The Patent Investor. Additionally, Bloomberg BNA recapped Kevin Noonan’s panel session on June 7 regarding the IPR proceedings before the PTAB and implications for biosimilars:

Experts Critical in Challenge Cases, Patent Board Judge Says, June 8

Seen & Heard on Social at BIO

To see more highlights from BIO 2016, check out our social media channels on Facebook, LinkedIn and Twitter. Share your favorite experiences and memories from BIO 2016 with us by searching for and using our BIO hashtag, #MBHBatBIO on Facebook and Twitter.

 

To see more photos from BIO, check out our Facebook photo album here: http://bit.ly/1U5rGT2

 

Be sure to visit us at booth no. 504, meet our attorneys and enter our raffle! #MBHBatBIO #BIO16 #BIOBAYBEST

 

 

Partner Sherri Oslick attended the Women In Bio Plenary Event at the Clift Hotel — in San Francisco, California.

 

 

Kevin Noonan, ready for #BIO16 day two!

 

 

#‎MBHBatBIO – Day 2: Partner Kevin Noonan “represented” the patentee during yesterday’s mock IPR proceeding in a session entitled, “Will the PTAB be a Road Block for Biotech? Lessons Learned from the First Three Years of Inter-Partes Review and Future Prospects.” What sessions at ‪#‎BIO16 have you enjoyed this week?

 

 

Booth visitors on Day 2 of #BIO2016. Stop by booth no. 504 throughout the rest of the conference!#MBHBatBIO